Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A new modality for immunosuppression: targeting the JAK/STAT pathway.

Nature reviews. Drug discovery - 1 Jul 2004

O'Shea John J, Pesu Marko, Borie Dominic C, Changelian Paul S

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunosuppression Therapy
Share to Immunosuppressive Agents
Share to Interleukin Receptor Common gamma Subunit
Share to Janus Kinase 3

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Molecular Structure

Share to Protein-Tyrosine Kinases

Share to Receptors, Interleukin-7

Share to Severe Combined Immunodeficiency

Source

Identifiers

PMID: 15232577
DOI: 10.1038/nrd1441

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A new modality for immunosuppression: targeting the JAK/STAT pathway.PMID 15232577Read ↗

New strategies for immunosuppression: interfering with cytokines by targeting the Jak/Stat pathwaySemantic proximity Read ↗

Janus Kinase-Signal Transducer and Activator of Transcription Inhibitors for the Treatment and Management of CancerSemantic proximity Read ↗

Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseasesSemantic proximity Read ↗

Insights into the role of the JAK/STAT signaling pathway in graft- versus -host diseaseSemantic proximity Read ↗

JAK3 inhibition as a new concept for immune suppression.Semantic proximity Read ↗

JAKs and STATs in immunity, immunodeficiency, and cancer.Semantic proximity Read ↗

JAK-STAT pathway in hematological malignancies: achievements, challenges and future perspectivesSemantic proximity Read ↗

The JAK/STAT3 axis: A comprehensive drug target for solid malignancies.Semantic proximity Read ↗

Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signalingSemantic proximity Read ↗

JAK3 inhibitors for the treatment of inflammatory and autoimmune diseases: a patent review (2016–present)Semantic proximity Read ↗

JAK kinase targeting in hematologic malignancies: a sinuous pathway from identification of genetic alterations towards clinical indications.Semantic proximity Read ↗

Targeting the Interleukin-6/Jak/Stat Pathway in Human MalignanciesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.